van der Bom JG - Search Results

1

Endogenous clotting factor activity and long-term outcome in patients with moderate haemophilia.

Fischer K, van der Bom JG, Mauser-Bunschoten EP, Roosendaal G, Beek FJ, de Kleijn P, Grobbee DE, van den Berg HM. Fischer K, et al. Among authors: van den berg hm, van der bom jg. Thromb Haemost. 2000 Dec;84(6):977-80. Thromb Haemost. 2000. PMID: 11154144

2

Antithrombin and atherosclerosis in the Rotterdam Study.

van der Bom JG, Bots ML, van Vliet HH, Pols HA, Hofman A, Grobbee DE. van der Bom JG, et al. Among authors: van vliet hh. Arterioscler Thromb Vasc Biol. 1996 Jul;16(7):864-7. doi: 10.1161/01.atv.16.7.864. Arterioscler Thromb Vasc Biol. 1996. PMID: 8673561

3

Reduced response to activated protein C is associated with increased risk for cerebrovascular disease.

van der Bom JG, Bots ML, Haverkate F, Slagboom PE, Meijer P, de Jong PT, Hofman A, Grobbee DE, Kluft C. van der Bom JG, et al. Ann Intern Med. 1996 Aug 15;125(4):265-9. doi: 10.7326/0003-4819-125-4-199608150-00002. Ann Intern Med. 1996. PMID: 8678388

4

Plasma fibrinogen in NIDDM: the Rotterdam study.

Missov RM, Stolk RP, van der Bom JG, Hofman A, Bots ML, Pols HA, Grobbee DE. Missov RM, et al. Among authors: van der bom jg. Diabetes Care. 1996 Feb;19(2):157-9. doi: 10.2337/diacare.19.2.157. Diabetes Care. 1996. PMID: 8718437

5

Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study.

van der Bom JG, de Knijff P, Haverkate F, Bots ML, Meijer P, de Jong PT, Hofman A, Kluft C, Grobbee DE. van der Bom JG, et al. Circulation. 1997 Jun 17;95(12):2623-7. doi: 10.1161/01.cir.95.12.2623. Circulation. 1997. PMID: 9193430

6

Seasonal variation in fibrinogen in the Rotterdam Study.

van der Bom JG, de Maat MP, Bots ML, Hofman A, Kluft C, Grobbee DE. van der Bom JG, et al. Thromb Haemost. 1997 Sep;78(3):1059-62. Thromb Haemost. 1997. PMID: 9308754

7

Elevated plasma fibrinogen: cause or consequence of cardiovascular disease?

van der Bom JG, de Maat MP, Bots ML, Haverkate F, de Jong PT, Hofman A, Kluft C, Grobbee DE. van der Bom JG, et al. Arterioscler Thromb Vasc Biol. 1998 Apr;18(4):621-5. doi: 10.1161/01.atv.18.4.621. Arterioscler Thromb Vasc Biol. 1998. PMID: 9555868

8

Fibrinolytic activity in peripheral atherosclerosis in the elderly.

van der Bom JG, Bots ML, Haverkate F, Meyer P, Hofman A, Grobbee DE, Kluft C. van der Bom JG, et al. Thromb Haemost. 1999 Feb;81(2):275-80. Thromb Haemost. 1999. PMID: 10064006

9

Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease.

van der Bom JG, Bots ML, Haverkate F, Meijer P, Hofman A, Kluft C, Grobbee DE. van der Bom JG, et al. Thromb Haemost. 2001 Feb;85(2):234-9. Thromb Haemost. 2001. PMID: 11246539

10

Long-term outcome of individualized prophylactic treatment of children with severe haemophilia.

van den Berg HM, Fischer K, Mauser-Bunschoten EP, Beek FJ, Roosendaal G, van der Bom JG, Nieuwenhuis HK. van den Berg HM, et al. Among authors: van der bom jg. Br J Haematol. 2001 Mar;112(3):561-5. doi: 10.1046/j.1365-2141.2001.02580.x. Br J Haematol. 2001. PMID: 11260054 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

311 results

Search Page